Loading clinical trials...
Loading clinical trials...
The study aims to observe changes in dopaminergic genes expression in peripheral tissue upon prolonged dopamine agonist treatment on patients with Restless Legs Syndrome (RLS). Similar studies in Park...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
HBC Immunology Inc
NCT07179406 · Restless Leg Syndrome (RLS), Spinal Cord Stimulation (SCS)
NCT07144631 · Restless Leg Disorder, Restless Leg Syndrome (RLS), and more
NCT06747741 · Elderly, Restless Leg Syndrome (RLS), and more
NCT07308080 · Restless Leg Syndrome (RLS)
NCT03018912 · Obstructive Sleep Apnea (OSA), Insomnia, and more
Alethios Inc
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions